Patent ID: 8679093

Claim:
A drug delivery device comprising: at least two housing units connected together end-to-end in a fixed, linear orientation, each housing unit having an exterior surface and an interior surface, the exterior surfaces of the connected housing units defining a sidewall of the device; at least two discrete dose units, each comprising a drug formulation comprising at least one drug, wherein each of the housing units has one of the discrete dose units disposed therewithin; at least one degradable timing member connected to the at least two housing units and separating the discrete dose units from one another; a first end piece defining a first end of the device; and second end piece defining a second end of the device distal to the first end of the device, the discrete dose units being located between the first and second end pieces within each of the housing units, wherein the device, when deployed in vivo, is adapted to release a first of the at least two discrete dose units following rupture of the first or second end piece, and subsequently to release a second of the at least two discrete dose units following rupture of the at least one degradable timing member separating the first of the at least two discrete dose units from the second of the at least two discrete dose units.